Increased Glucocorticoids in Pregnant Rats Reduces Fetal Growth and Placental Vascularisation

Research output: Contribution to conferenceAbstract

Abstract

Healthy placental vasculature is critical for appropriate fetal development and health outcomes. Understanding placental vascular morphology and fetal growth is crucial for developing future diagnostic approaches. This study aimed to investigate impacts of glucocorticoids on fetal growth and placental vascularisation. 20 time-mated Wistar rats were administered with either vehicle or 0.5 μg/ml dexamethasone acetate (DEX, a synthetic glucocorticoid), via drinking water from embryonic day 13 until the end of the experiment. Dams were then euthanised for tissue collection. Fetal and placental growth were assessed using weight and morphometric measures. Individual feto-placental arterial vasculatures were cast with Microfil. Then 3D high-resolution micro-CT images of the casts were reconstructed and then were visualised and analysed using Amira and Matlab. Fetal and whole placental weights in DEX-treated rats were decreased by 14.09% and 34.12% respectively (p<0.0002). Additionally, labyrinth (inner) and junctional (outer) placental weights were decreased in DEX group by 30.31% and 41.98% respectively (p<0.0001). Maternal DEX treatment significantly reduced fetal and placental sizes (p<0.001). The 3D micro-CT data showed that placental arterial vascularity and complexity were decreased in DEX treatment relative to controls. Our data confirms that maternal DEX treatment impairs fetal and placental growth. Further studies are on-going to investigate in-vivo placental function by using the non-invasive MRI and to determine how MRI outcomes correlate with placental vascular structure.
Original languageEnglish
Publication statusPublished - 3 Jun 2019
EventThe Second Murdoch University Annual Research Symposium - ECL4 Lecture Theatre, Murdoch University, Perth, Australia
Duration: 3 Jun 20193 Jun 2019
https://marswa.org

Conference

ConferenceThe Second Murdoch University Annual Research Symposium
Abbreviated titleMARS 2019
CountryAustralia
CityPerth
Period3/06/193/06/19
Internet address

Fingerprint

Fetal Development
Glucocorticoids
Weights and Measures
Blood Vessels
Mothers
Silicone Elastomers
Inner Ear
Drinking Water
Wistar Rats
Health

Cite this

Tongpob, Y., Xia, S., Feindel, K., & Mehnert, A. (2019). Increased Glucocorticoids in Pregnant Rats Reduces Fetal Growth and Placental Vascularisation. Abstract from The Second Murdoch University Annual Research Symposium, Perth, Australia.
Tongpob, Yutthapong ; Xia, Shushan ; Feindel, Kirk ; Mehnert, Andrew. / Increased Glucocorticoids in Pregnant Rats Reduces Fetal Growth and Placental Vascularisation. Abstract from The Second Murdoch University Annual Research Symposium, Perth, Australia.
@conference{4873c9a606e74d24b3ef8489f85d65f1,
title = "Increased Glucocorticoids in Pregnant Rats Reduces Fetal Growth and Placental Vascularisation",
abstract = "Healthy placental vasculature is critical for appropriate fetal development and health outcomes. Understanding placental vascular morphology and fetal growth is crucial for developing future diagnostic approaches. This study aimed to investigate impacts of glucocorticoids on fetal growth and placental vascularisation. 20 time-mated Wistar rats were administered with either vehicle or 0.5 μg/ml dexamethasone acetate (DEX, a synthetic glucocorticoid), via drinking water from embryonic day 13 until the end of the experiment. Dams were then euthanised for tissue collection. Fetal and placental growth were assessed using weight and morphometric measures. Individual feto-placental arterial vasculatures were cast with Microfil. Then 3D high-resolution micro-CT images of the casts were reconstructed and then were visualised and analysed using Amira and Matlab. Fetal and whole placental weights in DEX-treated rats were decreased by 14.09{\%} and 34.12{\%} respectively (p<0.0002). Additionally, labyrinth (inner) and junctional (outer) placental weights were decreased in DEX group by 30.31{\%} and 41.98{\%} respectively (p<0.0001). Maternal DEX treatment significantly reduced fetal and placental sizes (p<0.001). The 3D micro-CT data showed that placental arterial vascularity and complexity were decreased in DEX treatment relative to controls. Our data confirms that maternal DEX treatment impairs fetal and placental growth. Further studies are on-going to investigate in-vivo placental function by using the non-invasive MRI and to determine how MRI outcomes correlate with placental vascular structure.",
author = "Yutthapong Tongpob and Shushan Xia and Kirk Feindel and Andrew Mehnert",
year = "2019",
month = "6",
day = "3",
language = "English",
note = "The Second Murdoch University Annual Research Symposium, MARS 2019 ; Conference date: 03-06-2019 Through 03-06-2019",
url = "https://marswa.org",

}

Tongpob, Y, Xia, S, Feindel, K & Mehnert, A 2019, 'Increased Glucocorticoids in Pregnant Rats Reduces Fetal Growth and Placental Vascularisation' The Second Murdoch University Annual Research Symposium, Perth, Australia, 3/06/19 - 3/06/19, .

Increased Glucocorticoids in Pregnant Rats Reduces Fetal Growth and Placental Vascularisation. / Tongpob, Yutthapong; Xia, Shushan; Feindel, Kirk; Mehnert, Andrew.

2019. Abstract from The Second Murdoch University Annual Research Symposium, Perth, Australia.

Research output: Contribution to conferenceAbstract

TY - CONF

T1 - Increased Glucocorticoids in Pregnant Rats Reduces Fetal Growth and Placental Vascularisation

AU - Tongpob, Yutthapong

AU - Xia, Shushan

AU - Feindel, Kirk

AU - Mehnert, Andrew

PY - 2019/6/3

Y1 - 2019/6/3

N2 - Healthy placental vasculature is critical for appropriate fetal development and health outcomes. Understanding placental vascular morphology and fetal growth is crucial for developing future diagnostic approaches. This study aimed to investigate impacts of glucocorticoids on fetal growth and placental vascularisation. 20 time-mated Wistar rats were administered with either vehicle or 0.5 μg/ml dexamethasone acetate (DEX, a synthetic glucocorticoid), via drinking water from embryonic day 13 until the end of the experiment. Dams were then euthanised for tissue collection. Fetal and placental growth were assessed using weight and morphometric measures. Individual feto-placental arterial vasculatures were cast with Microfil. Then 3D high-resolution micro-CT images of the casts were reconstructed and then were visualised and analysed using Amira and Matlab. Fetal and whole placental weights in DEX-treated rats were decreased by 14.09% and 34.12% respectively (p<0.0002). Additionally, labyrinth (inner) and junctional (outer) placental weights were decreased in DEX group by 30.31% and 41.98% respectively (p<0.0001). Maternal DEX treatment significantly reduced fetal and placental sizes (p<0.001). The 3D micro-CT data showed that placental arterial vascularity and complexity were decreased in DEX treatment relative to controls. Our data confirms that maternal DEX treatment impairs fetal and placental growth. Further studies are on-going to investigate in-vivo placental function by using the non-invasive MRI and to determine how MRI outcomes correlate with placental vascular structure.

AB - Healthy placental vasculature is critical for appropriate fetal development and health outcomes. Understanding placental vascular morphology and fetal growth is crucial for developing future diagnostic approaches. This study aimed to investigate impacts of glucocorticoids on fetal growth and placental vascularisation. 20 time-mated Wistar rats were administered with either vehicle or 0.5 μg/ml dexamethasone acetate (DEX, a synthetic glucocorticoid), via drinking water from embryonic day 13 until the end of the experiment. Dams were then euthanised for tissue collection. Fetal and placental growth were assessed using weight and morphometric measures. Individual feto-placental arterial vasculatures were cast with Microfil. Then 3D high-resolution micro-CT images of the casts were reconstructed and then were visualised and analysed using Amira and Matlab. Fetal and whole placental weights in DEX-treated rats were decreased by 14.09% and 34.12% respectively (p<0.0002). Additionally, labyrinth (inner) and junctional (outer) placental weights were decreased in DEX group by 30.31% and 41.98% respectively (p<0.0001). Maternal DEX treatment significantly reduced fetal and placental sizes (p<0.001). The 3D micro-CT data showed that placental arterial vascularity and complexity were decreased in DEX treatment relative to controls. Our data confirms that maternal DEX treatment impairs fetal and placental growth. Further studies are on-going to investigate in-vivo placental function by using the non-invasive MRI and to determine how MRI outcomes correlate with placental vascular structure.

UR - https://marswa.org

M3 - Abstract

ER -

Tongpob Y, Xia S, Feindel K, Mehnert A. Increased Glucocorticoids in Pregnant Rats Reduces Fetal Growth and Placental Vascularisation. 2019. Abstract from The Second Murdoch University Annual Research Symposium, Perth, Australia.